Genomic Health Expands Oncotype DX Breast Cancer
June 3, 2008 · Filed Under Cancer Treatment · Comment
Genomic Health’s study confirms RT-PCR by Oncotype DX can deliver quantitative gene expression levels for assessing estrogen receptor (ER) and progesterone receptor (PR) status, which are critical factors in determining the use and benefit of hormonal therapy for the treatment of breast cancer. Read more

